DE69230069T2 - Steroide enthaltende zusammensetzungen zur anwendung am auge und ihre verwendung zur behandlung des glaukoms - Google Patents

Steroide enthaltende zusammensetzungen zur anwendung am auge und ihre verwendung zur behandlung des glaukoms

Info

Publication number
DE69230069T2
DE69230069T2 DE69230069T DE69230069T DE69230069T2 DE 69230069 T2 DE69230069 T2 DE 69230069T2 DE 69230069 T DE69230069 T DE 69230069T DE 69230069 T DE69230069 T DE 69230069T DE 69230069 T2 DE69230069 T2 DE 69230069T2
Authority
DE
Germany
Prior art keywords
pct
eye
date
compositions containing
treating glaucoma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69230069T
Other languages
German (de)
English (en)
Other versions
DE69230069D1 (de
Inventor
Gerard Schwadrohn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoire Theramex SAM
Original Assignee
Laboratoire Theramex SAM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9109017A external-priority patent/FR2679139B1/fr
Priority claimed from FR9109016A external-priority patent/FR2679138B1/fr
Priority claimed from FR9109015A external-priority patent/FR2679137B1/fr
Priority claimed from FR9110160A external-priority patent/FR2680108B1/fr
Application filed by Laboratoire Theramex SAM filed Critical Laboratoire Theramex SAM
Publication of DE69230069D1 publication Critical patent/DE69230069D1/de
Application granted granted Critical
Publication of DE69230069T2 publication Critical patent/DE69230069T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69230069T 1991-06-18 1992-06-18 Steroide enthaltende zusammensetzungen zur anwendung am auge und ihre verwendung zur behandlung des glaukoms Expired - Fee Related DE69230069T2 (de)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
FR9107412 1991-06-18
FR9109017A FR2679139B1 (fr) 1991-07-17 1991-07-17 Nouvelles compositions pharmaceutiques destinees a l'application oculaire renfermant un derive androstenique et leur procede de preparation.
FR9109016A FR2679138B1 (fr) 1991-07-17 1991-07-17 Compositions pharmaceutiques anti-glaucomateuses et leur procede d'obtention.
FR9109015A FR2679137B1 (fr) 1991-07-17 1991-07-17 Nouvelles compositions pharmaceutiques a base d'un derive pregnenique et leur procede de preparation.
FR9110160A FR2680108B1 (fr) 1991-08-09 1991-08-09 Nouvelles compositions pharmaceutiques a base de sterouides 6-hydroxymethyles et leur procede d'obtention.
PCT/FR1992/000549 WO1992022300A1 (fr) 1991-06-18 1992-06-18 Compositions oculaires contenant des steroïdes et leur utilisation pour le traitement du glaucome

Publications (2)

Publication Number Publication Date
DE69230069D1 DE69230069D1 (de) 1999-11-04
DE69230069T2 true DE69230069T2 (de) 2000-05-25

Family

ID=27515565

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69230069T Expired - Fee Related DE69230069T2 (de) 1991-06-18 1992-06-18 Steroide enthaltende zusammensetzungen zur anwendung am auge und ihre verwendung zur behandlung des glaukoms

Country Status (11)

Country Link
US (1) US5506220A (fr)
EP (1) EP0593520B1 (fr)
JP (1) JP3328729B2 (fr)
KR (1) KR100249555B1 (fr)
AT (1) ATE185071T1 (fr)
CA (1) CA2111699A1 (fr)
DE (1) DE69230069T2 (fr)
DK (1) DK0593520T3 (fr)
ES (1) ES2139602T3 (fr)
GR (1) GR3031967T3 (fr)
WO (1) WO1992022300A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2292239A3 (fr) * 2003-04-18 2011-03-30 Advanced Medicine Research Institute Remèdes à des affections, à usage ophtalmique
WO2004093882A1 (fr) * 2003-04-18 2004-11-04 Advanced Medicine Research Institute Remedes a appliquer sur l'oeil pour soigner differentes maladies
DE202006021081U1 (de) * 2005-07-12 2012-05-08 Dmi Biosciences, Inc. Produkte zur Behandlung von Krankheiten
CA2765883A1 (fr) * 2009-06-22 2010-12-29 Dmi Acquisition Corp. Procedes et produits de traitement de maladies
AU2010264524B2 (en) 2009-06-22 2015-03-19 Ampio Pharmaceuticals, Inc. Method for treatment of diseases
CN102134265B (zh) * 2009-12-29 2013-04-03 黄云生 一种合成6-甲基-17α-乙酰氧基-19-去甲孕甾-4,6-二烯-3,20-二酮的方法
CN103764151B (zh) 2011-05-20 2017-05-17 国家医疗保健研究所 Cb1受体拮抗剂
US10259839B2 (en) 2012-11-28 2019-04-16 Inserm (Institut National De La Sante Et De La Recherche Medicale) 3-(4′-substituted)-benzyl-ether derivatives of pregnenolone
AU2013361338A1 (en) 2012-12-19 2015-08-06 Ampio Pharmaceuticals, Inc. Method for treatment of diseases

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1515284A (en) * 1974-05-21 1978-06-21 Gastaud J Pharmaceutical compositions containing progestogens derived from the 17-alpha-hydroxy-19-nor-progesterone series
US4383992A (en) * 1982-02-08 1983-05-17 Lipari John M Water-soluble steroid compounds
US4617299A (en) * 1983-12-19 1986-10-14 Knepper Paul A Method for the prevention of ocular hypertension, treatment of glaucoma and treatment of ocular hypertension
US4863912A (en) * 1986-05-19 1989-09-05 New York Medical College Use of tetrahydrocortisol in glaucoma therapy
WO1987007141A1 (fr) * 1986-05-23 1987-12-03 New England Medical Center Hospitals, Inc. Methode de traitement du glaucome
FR2622194B1 (fr) * 1987-10-27 1990-03-23 Theramex Laboratoire Nouveaux derives de la 19-nor progesterone, leur procede d'obtention et les compositions pharmaceutiques en contenant
US4876250A (en) * 1988-10-31 1989-10-24 Alcon Laboratories, Inc. Methods for controlling ocular hypertension with angiostatic steroids
FR2645864B1 (fr) * 1989-04-13 1991-07-12 Theramex Nouveaux derives alcoyles en 17/21 de la 19-nor progesterone, leurs procedes d'obtention et les compositions pharmaceutiques en renfermant
FR2679236B1 (fr) 1991-07-18 1997-01-24 Theramex Nouveaux sterouides substitues en position 6, leurs procedes d'obtention et des compositions pharmaceutiques en renfermant.

Also Published As

Publication number Publication date
EP0593520B1 (fr) 1999-09-29
CA2111699A1 (fr) 1992-12-23
EP0593520A1 (fr) 1994-04-27
ATE185071T1 (de) 1999-10-15
DE69230069D1 (de) 1999-11-04
US5506220A (en) 1996-04-09
JP3328729B2 (ja) 2002-09-30
KR100249555B1 (ko) 2000-04-01
DK0593520T3 (da) 2000-04-03
GR3031967T3 (en) 2000-03-31
JPH06508362A (ja) 1994-09-22
ES2139602T3 (es) 2000-02-16
KR940701260A (ko) 1994-05-28
WO1992022300A1 (fr) 1992-12-23

Similar Documents

Publication Publication Date Title
DE59409312D1 (de) Imidazopyridine und ihre anwendung zur behandlung von magen-darm krankheiten
DE69521620D1 (de) Verwendung von 9-deoxyprostaglandinderivaten zur behandlung von glaukom
DE68929563D1 (de) Prostaglandin-Derivate zur Behandlung von Glaukom und ocularer Hypertension
ATE158717T1 (de) Verfahren und formulierungen zur kontrazeption und zur behandlung von benignen gynäkologischen störungen
DE69329240D1 (de) 17-ether und thioether von 4-aza-steroiden
DE69805973D1 (de) Behandlung von herzrythmusstörungen durch hemmung einer multifunktionalen calcium/calmodulin-abhängigen protein kinase
ATE238792T1 (de) Verwendung von makroliden zur behandlung von glaukom
ATE198708T1 (de) Verwendung von makrolid-verbindungen gegen augenerkrankungen
DE69012261D1 (de) Verwendung von Sertralin zur Behandlung verfrühter Ejakulation.
ATE221781T1 (de) Angiostatische verbindungen und zusammensetzungen zur behandlung des glc1a glaukoms
DE69413829D1 (de) Antiglucocorticoidsteroide zur behandlung von angststörungen
DE69230069T2 (de) Steroide enthaltende zusammensetzungen zur anwendung am auge und ihre verwendung zur behandlung des glaukoms
ATE152628T1 (de) Verwendung von parathormone, seinen biologisch aktiven fragmenten oder von verwandten peptiden zur behandlung von schwangerschaft
ATE180669T1 (de) Verwendung von pregnanderivaten zur behandlung von tumoren
ATE157010T1 (de) Amylin oder amylinanaloga enthaltende zusammensetzung, welche auch wahlweise insulin enthält, zur behandlung von anorexie und verwandten zuständen
DE69424679T2 (de) Zusammensetzung zur behandlung oder vorbeugung von herpes
ZA932025B (en) Agents for use as an anti-irritant
DE69427116D1 (de) Verwendung von 4'-iodo - 4 - deoxydoxorubicin zur behandlung von amyloidosis
GB9015774D0 (en) Novel treatment
DK0675721T3 (da) Farmaceutiske præparater omfattende contignasterolforbindelser

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee